Device / Technology News

RSS
SKY92 genetic subtyping signature better than current markers in predicting progress of multiple myeloma

SKY92 genetic subtyping signature better than current markers in predicting progress of multiple myeloma

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

NanoPass to supply MicronJet600 device for use with Immune Design's ZVex discovery platform

Al-Hidaya brings Medizone's AsepticSure systems into the Kingdom of Saudi Arabia to reduce MERS-coronavirus

Al-Hidaya brings Medizone's AsepticSure systems into the Kingdom of Saudi Arabia to reduce MERS-coronavirus

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX launches novel intra-ocular pressure monitoring device

Demand for improved capabilities, wireless connectivity drives Western and Eastern European MPM market

Demand for improved capabilities, wireless connectivity drives Western and Eastern European MPM market

CEVEC launches unique cell-expression system for scalable production of gene therapy vectors

CEVEC launches unique cell-expression system for scalable production of gene therapy vectors

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

Offers from Eppendorf Advantage to improve laboratory efficiency

Offers from Eppendorf Advantage to improve laboratory efficiency

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

PET imaging technique does not improve outcomes in esophageal cancer patients

PET imaging technique does not improve outcomes in esophageal cancer patients

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Thoratec begins SHIELD II U.S. clinical trial to examine use of HeartMate PHP in patients undergoing high-risk PCI

Mesothelioma website provides three new tips to combat disease

Mesothelioma website provides three new tips to combat disease

UCLA study questions value of BRCA genetic testing in general population

UCLA study questions value of BRCA genetic testing in general population

Researchers document accuracy of new tests for rapid diagnosis of drug-resistant forms of TB

Researchers document accuracy of new tests for rapid diagnosis of drug-resistant forms of TB

Researchers find intrinsic differences in mice’s neural stem cells using image-tracking technology

Researchers find intrinsic differences in mice’s neural stem cells using image-tracking technology

Free e-book provides advice for lowering breast cancer risk at every stage of life

Free e-book provides advice for lowering breast cancer risk at every stage of life

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Trajan launches prototype blood collection and storage device, hemaPEN

Trajan launches prototype blood collection and storage device, hemaPEN

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.